About: http://webisa.webdatacommons.org/213556317

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Ophthotech isn???t the only company to target PDGF???a startup in Waltham, MA called Kala Pharmaceuticals is developing a drug, for example, that blocks both VEGF and PDGF???but Ophthotech is the farthest along in development.
http://www.w3.org/ns/prov#wasQuotedFrom	xconomy.com